| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endoscopy, Gastrointestinal | 47 | 2024 | 117 | 9.540 |
Why?
|
| Gastroenterology | 16 | 2022 | 52 | 5.490 |
Why?
|
| Pediatrics | 20 | 2024 | 250 | 4.270 |
Why?
|
| Quality Improvement | 12 | 2024 | 410 | 3.690 |
Why?
|
| Conscious Sedation | 15 | 2023 | 49 | 3.350 |
Why?
|
| Child | 59 | 2024 | 4238 | 2.640 |
Why?
|
| Colonoscopy | 14 | 2022 | 102 | 2.420 |
Why?
|
| Endoscopy | 10 | 2023 | 95 | 1.820 |
Why?
|
| Deep Sedation | 6 | 2018 | 9 | 1.700 |
Why?
|
| Hypnotics and Sedatives | 8 | 2023 | 71 | 1.590 |
Why?
|
| Child, Preschool | 28 | 2024 | 1812 | 1.500 |
Why?
|
| Humans | 125 | 2024 | 58820 | 1.370 |
Why?
|
| Propofol | 5 | 2023 | 27 | 1.280 |
Why?
|
| Gastrointestinal Diseases | 5 | 2024 | 72 | 1.240 |
Why?
|
| Capnography | 3 | 2017 | 8 | 1.170 |
Why?
|
| Gastrostomy | 4 | 2015 | 33 | 1.140 |
Why?
|
| Pancreatitis | 4 | 2023 | 99 | 1.130 |
Why?
|
| Barrett Esophagus | 3 | 2023 | 34 | 1.120 |
Why?
|
| Clinical Competence | 10 | 2019 | 669 | 1.030 |
Why?
|
| Vomiting | 2 | 2018 | 133 | 1.020 |
Why?
|
| Infant | 18 | 2020 | 1507 | 0.940 |
Why?
|
| Colitis, Ulcerative | 3 | 2017 | 78 | 0.850 |
Why?
|
| Milk Hypersensitivity | 1 | 2022 | 1 | 0.830 |
Why?
|
| Colonic Polyps | 1 | 2022 | 25 | 0.820 |
Why?
|
| Benchmarking | 1 | 2023 | 134 | 0.810 |
Why?
|
| Medication Errors | 2 | 2016 | 115 | 0.810 |
Why?
|
| Food Hypersensitivity | 1 | 2022 | 16 | 0.810 |
Why?
|
| Autistic Disorder | 3 | 2016 | 167 | 0.760 |
Why?
|
| Adolescent | 27 | 2024 | 5862 | 0.750 |
Why?
|
| Inflammatory Bowel Diseases | 4 | 2015 | 100 | 0.730 |
Why?
|
| Bezoars | 1 | 2020 | 4 | 0.730 |
Why?
|
| Female | 47 | 2024 | 30545 | 0.710 |
Why?
|
| Referral and Consultation | 3 | 2015 | 405 | 0.710 |
Why?
|
| Gastroscopy | 3 | 2015 | 24 | 0.700 |
Why?
|
| Hospitals, Pediatric | 5 | 2013 | 38 | 0.690 |
Why?
|
| Gastroenterologists | 2 | 2016 | 10 | 0.680 |
Why?
|
| Nursing Staff, Hospital | 2 | 2011 | 72 | 0.670 |
Why?
|
| Anesthetics, General | 1 | 2019 | 2 | 0.670 |
Why?
|
| Practice Patterns, Physicians' | 6 | 2017 | 708 | 0.670 |
Why?
|
| Proton Pump Inhibitors | 3 | 2015 | 39 | 0.670 |
Why?
|
| Practice Guidelines as Topic | 8 | 2015 | 701 | 0.670 |
Why?
|
| Constipation | 3 | 2015 | 16 | 0.660 |
Why?
|
| Endoscopy, Digestive System | 6 | 2017 | 29 | 0.660 |
Why?
|
| Enteral Nutrition | 3 | 2014 | 55 | 0.650 |
Why?
|
| Electronic Health Records | 2 | 2020 | 346 | 0.640 |
Why?
|
| Monitoring, Intraoperative | 4 | 2018 | 45 | 0.630 |
Why?
|
| Patient Safety | 3 | 2018 | 234 | 0.620 |
Why?
|
| Male | 40 | 2024 | 27258 | 0.610 |
Why?
|
| Esophagus | 3 | 2015 | 51 | 0.600 |
Why?
|
| Endosonography | 7 | 2024 | 33 | 0.600 |
Why?
|
| Gastroesophageal Reflux | 3 | 2015 | 76 | 0.580 |
Why?
|
| Analgesia | 3 | 2013 | 31 | 0.580 |
Why?
|
| Antiemetics | 1 | 2018 | 96 | 0.580 |
Why?
|
| Consensus | 7 | 2024 | 189 | 0.570 |
Why?
|
| Attitude of Health Personnel | 4 | 2011 | 554 | 0.570 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2017 | 41 | 0.550 |
Why?
|
| Artificial Intelligence | 3 | 2024 | 161 | 0.540 |
Why?
|
| Parenteral Nutrition, Home | 1 | 2016 | 4 | 0.540 |
Why?
|
| Parenteral Nutrition Solutions | 1 | 2016 | 5 | 0.540 |
Why?
|
| Erythrocyte Transfusion | 3 | 2014 | 75 | 0.510 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2015 | 24 | 0.490 |
Why?
|
| Marijuana Abuse | 1 | 2015 | 19 | 0.490 |
Why?
|
| Esophageal Perforation | 2 | 2014 | 6 | 0.490 |
Why?
|
| Patient Admission | 1 | 2017 | 184 | 0.490 |
Why?
|
| Hemoglobins | 3 | 2014 | 139 | 0.490 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2019 | 737 | 0.490 |
Why?
|
| Postoperative Complications | 5 | 2019 | 1114 | 0.490 |
Why?
|
| Colon | 3 | 2017 | 136 | 0.490 |
Why?
|
| Severity of Illness Index | 6 | 2017 | 1437 | 0.490 |
Why?
|
| Cannabinoids | 1 | 2015 | 34 | 0.480 |
Why?
|
| Drug Prescriptions | 1 | 2016 | 185 | 0.470 |
Why?
|
| Esophageal Stenosis | 1 | 2014 | 4 | 0.470 |
Why?
|
| Esophageal Atresia | 1 | 2014 | 10 | 0.470 |
Why?
|
| Intestine, Small | 2 | 2015 | 72 | 0.460 |
Why?
|
| Feeding and Eating Disorders of Childhood | 1 | 2013 | 1 | 0.460 |
Why?
|
| Gastrointestinal Hemorrhage | 4 | 2016 | 85 | 0.440 |
Why?
|
| Intestinal Mucosa | 2 | 2017 | 222 | 0.440 |
Why?
|
| Fundoplication | 1 | 2013 | 18 | 0.430 |
Why?
|
| Societies, Medical | 8 | 2019 | 325 | 0.430 |
Why?
|
| Patient Handoff | 1 | 2013 | 18 | 0.430 |
Why?
|
| Hospitalization | 3 | 2020 | 1270 | 0.420 |
Why?
|
| Health Resources | 1 | 2013 | 87 | 0.410 |
Why?
|
| Infant, Newborn | 8 | 2020 | 1299 | 0.400 |
Why?
|
| Mesalamine | 1 | 2011 | 4 | 0.400 |
Why?
|
| Anesthesia | 4 | 2018 | 50 | 0.400 |
Why?
|
| United States | 12 | 2023 | 7432 | 0.390 |
Why?
|
| Azathioprine | 1 | 2011 | 22 | 0.390 |
Why?
|
| Stents | 2 | 2015 | 432 | 0.380 |
Why?
|
| Hematologic Neoplasms | 1 | 2011 | 46 | 0.370 |
Why?
|
| Manikins | 1 | 2011 | 20 | 0.370 |
Why?
|
| Secretin | 2 | 2001 | 6 | 0.370 |
Why?
|
| Self Report | 2 | 2024 | 364 | 0.370 |
Why?
|
| Education, Medical, Continuing | 3 | 2017 | 97 | 0.370 |
Why?
|
| Child Nutritional Physiological Phenomena | 2 | 2001 | 29 | 0.360 |
Why?
|
| Colectomy | 1 | 2011 | 96 | 0.360 |
Why?
|
| Clinical Trials as Topic | 3 | 2018 | 431 | 0.360 |
Why?
|
| Primary Health Care | 2 | 2015 | 640 | 0.360 |
Why?
|
| Inservice Training | 1 | 2011 | 81 | 0.350 |
Why?
|
| Models, Anatomic | 1 | 2010 | 55 | 0.350 |
Why?
|
| Celiac Disease | 1 | 2010 | 17 | 0.350 |
Why?
|
| Intussusception | 1 | 2010 | 12 | 0.350 |
Why?
|
| Internship and Residency | 4 | 2015 | 694 | 0.340 |
Why?
|
| Hemostasis, Endoscopic | 3 | 2014 | 4 | 0.340 |
Why?
|
| Esophagoscopy | 3 | 2015 | 26 | 0.340 |
Why?
|
| Psychomotor Agitation | 1 | 2009 | 19 | 0.340 |
Why?
|
| Fellowships and Scholarships | 1 | 2010 | 92 | 0.330 |
Why?
|
| Prospective Studies | 7 | 2018 | 3071 | 0.330 |
Why?
|
| Retrospective Studies | 10 | 2017 | 5921 | 0.330 |
Why?
|
| Anesthesiology | 2 | 2018 | 39 | 0.320 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 4 | 2016 | 50 | 0.320 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2011 | 310 | 0.320 |
Why?
|
| Boston | 5 | 2014 | 325 | 0.320 |
Why?
|
| Midazolam | 1 | 2008 | 12 | 0.310 |
Why?
|
| Endpoint Determination | 2 | 2018 | 24 | 0.300 |
Why?
|
| Computer Simulation | 1 | 2010 | 447 | 0.300 |
Why?
|
| Fentanyl | 1 | 2008 | 69 | 0.290 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 864 | 0.280 |
Why?
|
| Biopsy, Needle | 1 | 2007 | 125 | 0.280 |
Why?
|
| Health Care Surveys | 1 | 2007 | 278 | 0.270 |
Why?
|
| Adult | 15 | 2022 | 15596 | 0.270 |
Why?
|
| Obesity | 5 | 2022 | 1178 | 0.270 |
Why?
|
| Neuroendocrine Tumors | 2 | 2017 | 23 | 0.270 |
Why?
|
| Crohn Disease | 2 | 2020 | 105 | 0.260 |
Why?
|
| Gastrointestinal Stromal Tumors | 2 | 2017 | 20 | 0.260 |
Why?
|
| Cecum | 2 | 2022 | 15 | 0.260 |
Why?
|
| Ileum | 2 | 2022 | 20 | 0.260 |
Why?
|
| Colitis | 3 | 2017 | 75 | 0.250 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2016 | 49 | 0.250 |
Why?
|
| Breast Feeding | 3 | 2002 | 138 | 0.250 |
Why?
|
| Milk | 2 | 2022 | 50 | 0.250 |
Why?
|
| Digestive System Diseases | 2 | 2015 | 15 | 0.250 |
Why?
|
| Monitoring, Physiologic | 3 | 2017 | 151 | 0.250 |
Why?
|
| Gastrointestinal Neoplasms | 2 | 2017 | 31 | 0.250 |
Why?
|
| North America | 5 | 2017 | 109 | 0.250 |
Why?
|
| Cattle | 2 | 2022 | 301 | 0.240 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2016 | 104 | 0.240 |
Why?
|
| Length of Stay | 3 | 2017 | 759 | 0.240 |
Why?
|
| Myotomy | 1 | 2024 | 13 | 0.240 |
Why?
|
| Cathartics | 2 | 2015 | 11 | 0.240 |
Why?
|
| Bariatric Surgery | 2 | 2015 | 44 | 0.240 |
Why?
|
| Infusions, Intravenous | 3 | 2015 | 170 | 0.230 |
Why?
|
| Anesthesia, General | 3 | 2016 | 45 | 0.230 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2022 | 63 | 0.230 |
Why?
|
| Respiration, Artificial | 2 | 2017 | 284 | 0.230 |
Why?
|
| Comorbidity | 2 | 2020 | 1083 | 0.220 |
Why?
|
| Oximetry | 2 | 2017 | 47 | 0.220 |
Why?
|
| Precancerous Conditions | 2 | 2015 | 72 | 0.220 |
Why?
|
| Multivariate Analysis | 3 | 2020 | 925 | 0.220 |
Why?
|
| Lymphoma | 2 | 2016 | 98 | 0.220 |
Why?
|
| Abdominal Pain | 2 | 2014 | 91 | 0.210 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 4 | 2017 | 15 | 0.210 |
Why?
|
| Liver | 1 | 2007 | 772 | 0.210 |
Why?
|
| Pancreatic Neoplasms | 2 | 2016 | 315 | 0.210 |
Why?
|
| Risk Factors | 9 | 2018 | 4971 | 0.210 |
Why?
|
| Publishing | 1 | 2023 | 89 | 0.210 |
Why?
|
| Diet Fads | 1 | 2002 | 4 | 0.210 |
Why?
|
| Infant Formula | 1 | 2022 | 12 | 0.210 |
Why?
|
| Stomach | 2 | 2020 | 84 | 0.200 |
Why?
|
| Diet, Reducing | 1 | 2002 | 31 | 0.200 |
Why?
|
| Milk Proteins | 1 | 2022 | 44 | 0.200 |
Why?
|
| Immunoglobulin E | 1 | 2022 | 84 | 0.200 |
Why?
|
| Child Language | 1 | 2001 | 9 | 0.200 |
Why?
|
| Acute Disease | 1 | 2023 | 649 | 0.200 |
Why?
|
| Adiposity | 1 | 2022 | 79 | 0.200 |
Why?
|
| Physicians | 2 | 2021 | 428 | 0.200 |
Why?
|
| Food Preferences | 1 | 2002 | 55 | 0.200 |
Why?
|
| Gastrointestinal Agents | 1 | 2001 | 27 | 0.190 |
Why?
|
| Risk Assessment | 4 | 2018 | 1893 | 0.190 |
Why?
|
| Disease Management | 2 | 2013 | 219 | 0.190 |
Why?
|
| Survival Analysis | 2 | 2013 | 550 | 0.190 |
Why?
|
| Child Behavior | 1 | 2001 | 67 | 0.190 |
Why?
|
| Anesthetics, Intravenous | 3 | 2018 | 27 | 0.190 |
Why?
|
| Reproducibility of Results | 6 | 2024 | 1537 | 0.190 |
Why?
|
| Adenocarcinoma | 2 | 2015 | 320 | 0.190 |
Why?
|
| Equipment Design | 2 | 2014 | 313 | 0.190 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2017 | 662 | 0.190 |
Why?
|
| Faculty, Medical | 1 | 2023 | 198 | 0.190 |
Why?
|
| Leadership | 1 | 2023 | 196 | 0.190 |
Why?
|
| Quality Indicators, Health Care | 1 | 2024 | 328 | 0.180 |
Why?
|
| Age Factors | 4 | 2015 | 1514 | 0.180 |
Why?
|
| Curriculum | 4 | 2012 | 540 | 0.180 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2000 | 16 | 0.180 |
Why?
|
| Statistics, Nonparametric | 3 | 2010 | 207 | 0.180 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2000 | 11 | 0.180 |
Why?
|
| Anticoagulants | 2 | 2015 | 485 | 0.180 |
Why?
|
| Indians, North American | 2 | 1997 | 26 | 0.170 |
Why?
|
| Capsule Endoscopy | 2 | 2017 | 37 | 0.170 |
Why?
|
| Odds Ratio | 2 | 2014 | 769 | 0.170 |
Why?
|
| Hair | 1 | 2020 | 77 | 0.170 |
Why?
|
| Foreign Bodies | 1 | 2020 | 43 | 0.170 |
Why?
|
| Liver Transplantation | 2 | 1999 | 185 | 0.170 |
Why?
|
| Surveys and Questionnaires | 5 | 2024 | 2560 | 0.170 |
Why?
|
| Social Class | 1 | 2020 | 123 | 0.170 |
Why?
|
| Follow-Up Studies | 4 | 2014 | 2316 | 0.160 |
Why?
|
| Diet | 1 | 2024 | 631 | 0.160 |
Why?
|
| Internet | 2 | 2017 | 455 | 0.160 |
Why?
|
| Intestinal Perforation | 2 | 2016 | 14 | 0.160 |
Why?
|
| Time Factors | 3 | 2019 | 3544 | 0.160 |
Why?
|
| Living Donors | 1 | 1999 | 62 | 0.160 |
Why?
|
| United States Food and Drug Administration | 1 | 2019 | 95 | 0.160 |
Why?
|
| Organ Transplantation | 1 | 1999 | 51 | 0.160 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2019 | 86 | 0.160 |
Why?
|
| Treatment Outcome | 7 | 2020 | 5096 | 0.160 |
Why?
|
| Postoperative Hemorrhage | 2 | 2015 | 32 | 0.150 |
Why?
|
| Patient Outcome Assessment | 1 | 2018 | 56 | 0.150 |
Why?
|
| Stress, Psychological | 2 | 2014 | 438 | 0.150 |
Why?
|
| Physical Examination | 2 | 2015 | 103 | 0.150 |
Why?
|
| Cohort Studies | 4 | 2024 | 2428 | 0.150 |
Why?
|
| Medical Staff Privileges | 1 | 2017 | 9 | 0.140 |
Why?
|
| Checklist | 2 | 2015 | 73 | 0.140 |
Why?
|
| Bradycardia | 1 | 2017 | 34 | 0.140 |
Why?
|
| Leiomyoma | 1 | 2017 | 17 | 0.140 |
Why?
|
| Hemorrhage | 2 | 2016 | 276 | 0.140 |
Why?
|
| Credentialing | 1 | 2017 | 15 | 0.140 |
Why?
|
| Physician's Role | 1 | 1998 | 118 | 0.140 |
Why?
|
| Certification | 1 | 2017 | 48 | 0.140 |
Why?
|
| Sensitivity and Specificity | 3 | 2014 | 1090 | 0.140 |
Why?
|
| Biomedical Research | 2 | 2017 | 247 | 0.140 |
Why?
|
| Cholangitis | 1 | 2016 | 12 | 0.140 |
Why?
|
| Ileal Diseases | 1 | 2016 | 5 | 0.140 |
Why?
|
| Jejunal Diseases | 1 | 2016 | 8 | 0.140 |
Why?
|
| Duodenal Diseases | 1 | 2016 | 17 | 0.140 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 5 | 0.140 |
Why?
|
| Cholecystitis | 1 | 2016 | 29 | 0.140 |
Why?
|
| Anesthesiologists | 1 | 2016 | 13 | 0.130 |
Why?
|
| Biopsy | 2 | 2015 | 372 | 0.130 |
Why?
|
| Pancreatic Pseudocyst | 1 | 2016 | 13 | 0.130 |
Why?
|
| Telemedicine | 1 | 2021 | 327 | 0.130 |
Why?
|
| Pancreatitis, Acute Necrotizing | 1 | 2016 | 25 | 0.130 |
Why?
|
| Educational Measurement | 2 | 2015 | 204 | 0.130 |
Why?
|
| Duodenal Neoplasms | 1 | 2015 | 5 | 0.130 |
Why?
|
| Blood Loss, Surgical | 1 | 2015 | 54 | 0.130 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 2015 | 6 | 0.130 |
Why?
|
| Ampulla of Vater | 1 | 2015 | 13 | 0.130 |
Why?
|
| Dyspepsia | 1 | 2015 | 2 | 0.130 |
Why?
|
| Young Adult | 6 | 2020 | 4270 | 0.130 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 893 | 0.130 |
Why?
|
| Culturally Competent Care | 1 | 2015 | 15 | 0.130 |
Why?
|
| Histamine H2 Antagonists | 1 | 2015 | 11 | 0.130 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2015 | 9 | 0.130 |
Why?
|
| Pancreatic Diseases | 1 | 2015 | 39 | 0.130 |
Why?
|
| Amitriptyline | 1 | 2015 | 8 | 0.120 |
Why?
|
| 2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2015 | 6 | 0.120 |
Why?
|
| Research Design | 1 | 2018 | 561 | 0.120 |
Why?
|
| Adenoma | 1 | 2015 | 62 | 0.120 |
Why?
|
| Drainage | 1 | 2016 | 144 | 0.120 |
Why?
|
| Bile Ducts | 1 | 2015 | 22 | 0.120 |
Why?
|
| Intestinal Diseases | 1 | 2015 | 34 | 0.120 |
Why?
|
| Biliary Tract Diseases | 1 | 2015 | 18 | 0.120 |
Why?
|
| Helicobacter Infections | 1 | 2015 | 55 | 0.120 |
Why?
|
| False Positive Reactions | 1 | 2015 | 74 | 0.120 |
Why?
|
| Respiratory Insufficiency | 1 | 2017 | 147 | 0.120 |
Why?
|
| Helicobacter pylori | 1 | 2015 | 58 | 0.120 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 819 | 0.120 |
Why?
|
| Disabled Children | 1 | 2015 | 32 | 0.120 |
Why?
|
| Constriction, Pathologic | 1 | 2015 | 98 | 0.120 |
Why?
|
| Animals | 3 | 2022 | 19483 | 0.120 |
Why?
|
| Drug Interactions | 1 | 2015 | 115 | 0.120 |
Why?
|
| Endoscopes, Gastrointestinal | 2 | 2015 | 2 | 0.120 |
Why?
|
| Attitude to Health | 1 | 1997 | 274 | 0.120 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2014 | 11 | 0.120 |
Why?
|
| Cooperative Behavior | 1 | 2016 | 216 | 0.120 |
Why?
|
| Pharmacists | 1 | 2016 | 123 | 0.120 |
Why?
|
| Stomach Neoplasms | 1 | 2015 | 71 | 0.120 |
Why?
|
| Clostridium Infections | 1 | 2015 | 46 | 0.120 |
Why?
|
| Fibrinolytic Agents | 1 | 2015 | 163 | 0.120 |
Why?
|
| Granulation Tissue | 1 | 2014 | 4 | 0.120 |
Why?
|
| Ulcer | 1 | 2014 | 12 | 0.120 |
Why?
|
| Dilatation | 1 | 2014 | 29 | 0.120 |
Why?
|
| Diagnostic Errors | 1 | 2015 | 98 | 0.120 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2014 | 44 | 0.110 |
Why?
|
| Medical Informatics Applications | 1 | 2014 | 15 | 0.110 |
Why?
|
| Kidney Calculi | 1 | 2014 | 17 | 0.110 |
Why?
|
| Patient-Centered Care | 1 | 2017 | 245 | 0.110 |
Why?
|
| Child Mortality | 1 | 2013 | 7 | 0.110 |
Why?
|
| Operative Blood Salvage | 1 | 2013 | 1 | 0.110 |
Why?
|
| Prosthesis Failure | 1 | 2014 | 69 | 0.110 |
Why?
|
| Anastomosis, Surgical | 1 | 2014 | 94 | 0.110 |
Why?
|
| Obesity, Morbid | 1 | 2015 | 90 | 0.110 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 432 | 0.110 |
Why?
|
| Guidelines as Topic | 1 | 2014 | 158 | 0.110 |
Why?
|
| Urolithiasis | 1 | 2013 | 4 | 0.110 |
Why?
|
| Esophageal pH Monitoring | 1 | 2013 | 2 | 0.110 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2015 | 248 | 0.110 |
Why?
|
| Deglutition Disorders | 1 | 2013 | 43 | 0.110 |
Why?
|
| Perioperative Care | 1 | 2014 | 74 | 0.110 |
Why?
|
| Diet Therapy | 1 | 2013 | 14 | 0.110 |
Why?
|
| Incidence | 2 | 2013 | 1226 | 0.110 |
Why?
|
| Logistic Models | 1 | 2017 | 1245 | 0.110 |
Why?
|
| Delphi Technique | 3 | 2022 | 81 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2014 | 139 | 0.110 |
Why?
|
| Sexuality | 1 | 2013 | 23 | 0.110 |
Why?
|
| Thromboembolism | 1 | 2013 | 70 | 0.110 |
Why?
|
| Pelvic Pain | 1 | 2013 | 20 | 0.110 |
Why?
|
| Patient Selection | 1 | 2015 | 439 | 0.100 |
Why?
|
| Feasibility Studies | 2 | 2014 | 512 | 0.100 |
Why?
|
| Headache | 1 | 2013 | 63 | 0.100 |
Why?
|
| Erythrocytes | 1 | 2013 | 153 | 0.100 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 260 | 0.100 |
Why?
|
| Students | 1 | 2014 | 207 | 0.100 |
Why?
|
| Health Promotion | 1 | 1997 | 489 | 0.100 |
Why?
|
| Geriatric Assessment | 1 | 2013 | 161 | 0.100 |
Why?
|
| Prognosis | 2 | 2014 | 1561 | 0.100 |
Why?
|
| Esophageal Neoplasms | 1 | 2012 | 76 | 0.100 |
Why?
|
| Neoplasm Staging | 1 | 2013 | 446 | 0.100 |
Why?
|
| Child Abuse | 1 | 2013 | 87 | 0.100 |
Why?
|
| Social Support | 1 | 2014 | 356 | 0.100 |
Why?
|
| Infliximab | 1 | 2011 | 52 | 0.100 |
Why?
|
| Nutritional Requirements | 2 | 2002 | 30 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 578 | 0.100 |
Why?
|
| Probability | 2 | 2010 | 171 | 0.090 |
Why?
|
| Pulmonary Embolism | 1 | 2013 | 169 | 0.090 |
Why?
|
| Thrombosis | 1 | 2013 | 193 | 0.090 |
Why?
|
| Brain | 1 | 2019 | 1475 | 0.090 |
Why?
|
| Data Collection | 2 | 2014 | 381 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2012 | 233 | 0.090 |
Why?
|
| Regression Analysis | 1 | 2011 | 485 | 0.090 |
Why?
|
| Emergencies | 1 | 2011 | 113 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 254 | 0.090 |
Why?
|
| Patient Simulation | 1 | 2010 | 66 | 0.090 |
Why?
|
| Nursing Records | 1 | 2009 | 10 | 0.090 |
Why?
|
| Teaching | 1 | 2010 | 151 | 0.080 |
Why?
|
| Workload | 1 | 2010 | 118 | 0.080 |
Why?
|
| Analgesics | 2 | 2014 | 100 | 0.080 |
Why?
|
| Continuity of Patient Care | 1 | 2010 | 168 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 711 | 0.080 |
Why?
|
| Stress, Physiological | 1 | 2010 | 185 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 402 | 0.080 |
Why?
|
| Quality of Health Care | 2 | 2010 | 512 | 0.080 |
Why?
|
| Anesthesia Recovery Period | 1 | 2008 | 6 | 0.080 |
Why?
|
| Radiography | 1 | 2010 | 505 | 0.080 |
Why?
|
| Anesthesia, Intravenous | 1 | 2007 | 14 | 0.070 |
Why?
|
| Anesthesia, Inhalation | 1 | 2007 | 15 | 0.070 |
Why?
|
| Hospitals, Teaching | 1 | 2008 | 101 | 0.070 |
Why?
|
| Uncertainty | 1 | 2007 | 32 | 0.070 |
Why?
|
| Radiology, Interventional | 1 | 2007 | 27 | 0.070 |
Why?
|
| Case-Control Studies | 3 | 2015 | 1048 | 0.070 |
Why?
|
| Emergency Service, Hospital | 1 | 2015 | 1010 | 0.070 |
Why?
|
| Linear Models | 1 | 2008 | 418 | 0.070 |
Why?
|
| Immunosuppressive Agents | 2 | 2017 | 291 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 806 | 0.070 |
Why?
|
| Parents | 2 | 2001 | 375 | 0.070 |
Why?
|
| Analysis of Variance | 2 | 2010 | 576 | 0.060 |
Why?
|
| Informed Consent | 2 | 2017 | 129 | 0.060 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 2442 | 0.060 |
Why?
|
| Ablation Techniques | 2 | 2016 | 22 | 0.060 |
Why?
|
| Double-Blind Method | 1 | 2006 | 679 | 0.060 |
Why?
|
| Middle Aged | 5 | 2014 | 16117 | 0.060 |
Why?
|
| Role | 2 | 2014 | 14 | 0.060 |
Why?
|
| Nutrition Assessment | 1 | 2024 | 58 | 0.060 |
Why?
|
| Diet Surveys | 1 | 2024 | 77 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2020 | 830 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2016 | 1445 | 0.060 |
Why?
|
| Pregnancy | 2 | 2001 | 2325 | 0.050 |
Why?
|
| Benzodiazepines | 2 | 2018 | 97 | 0.050 |
Why?
|
| Massachusetts | 1 | 2008 | 2075 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2016 | 2013 | 0.050 |
Why?
|
| Rickets | 1 | 2001 | 1 | 0.050 |
Why?
|
| Injections, Intravenous | 1 | 2001 | 146 | 0.050 |
Why?
|
| Infant Food | 1 | 2001 | 3 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2001 | 134 | 0.050 |
Why?
|
| Creatine | 1 | 2001 | 26 | 0.050 |
Why?
|
| Vitamin A | 1 | 2001 | 27 | 0.050 |
Why?
|
| Diarrhea | 1 | 2001 | 72 | 0.050 |
Why?
|
| Algorithms | 2 | 2017 | 981 | 0.050 |
Why?
|
| Sucralfate | 1 | 2020 | 2 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2014 | 727 | 0.040 |
Why?
|
| Electric Power Supplies | 1 | 2020 | 7 | 0.040 |
Why?
|
| Deglutition | 1 | 2020 | 19 | 0.040 |
Why?
|
| Overweight | 1 | 2022 | 246 | 0.040 |
Why?
|
| Intestinal Obstruction | 1 | 2020 | 47 | 0.040 |
Why?
|
| Infant, Premature | 1 | 2001 | 173 | 0.040 |
Why?
|
| Eating | 1 | 2020 | 139 | 0.040 |
Why?
|
| Mycophenolic Acid | 1 | 1999 | 32 | 0.040 |
Why?
|
| Ethics, Medical | 1 | 1999 | 38 | 0.040 |
Why?
|
| Cyclosporine | 1 | 1999 | 56 | 0.040 |
Why?
|
| Self-Assessment | 1 | 2019 | 53 | 0.040 |
Why?
|
| Prednisone | 1 | 1999 | 79 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2001 | 243 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2001 | 909 | 0.040 |
Why?
|
| Feeding Behavior | 1 | 2000 | 313 | 0.040 |
Why?
|
| Granular Cell Tumor | 1 | 2017 | 2 | 0.040 |
Why?
|
| Endoscopic Mucosal Resection | 1 | 2017 | 4 | 0.040 |
Why?
|
| Contraindications, Procedure | 1 | 2017 | 3 | 0.040 |
Why?
|
| District of Columbia | 1 | 2017 | 11 | 0.040 |
Why?
|
| Lipoma | 1 | 2017 | 15 | 0.040 |
Why?
|
| Choristoma | 1 | 2017 | 23 | 0.040 |
Why?
|
| Iowa | 1 | 1997 | 19 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2018 | 171 | 0.030 |
Why?
|
| Treatment Refusal | 1 | 2017 | 60 | 0.030 |
Why?
|
| Duodenoscopes | 1 | 2016 | 3 | 0.030 |
Why?
|
| Observer Variation | 1 | 2017 | 201 | 0.030 |
Why?
|
| Embolism, Air | 1 | 2016 | 9 | 0.030 |
Why?
|
| Sphincterotomy, Endoscopic | 1 | 2016 | 8 | 0.030 |
Why?
|
| Balloon Enteroscopy | 1 | 2016 | 1 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2017 | 71 | 0.030 |
Why?
|
| Injections, Intralesional | 1 | 2016 | 12 | 0.030 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2016 | 17 | 0.030 |
Why?
|
| Pancreas | 1 | 2017 | 145 | 0.030 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2016 | 31 | 0.030 |
Why?
|
| Aged | 4 | 2014 | 13210 | 0.030 |
Why?
|
| Solvents | 1 | 2016 | 58 | 0.030 |
Why?
|
| Angiography | 1 | 2016 | 145 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2016 | 88 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 151 | 0.030 |
Why?
|
| Double-Balloon Enteroscopy | 1 | 2015 | 1 | 0.030 |
Why?
|
| Polyps | 1 | 2015 | 5 | 0.030 |
Why?
|
| Metaplasia | 1 | 2015 | 18 | 0.030 |
Why?
|
| Choledocholithiasis | 1 | 2015 | 5 | 0.030 |
Why?
|
| Sphincter of Oddi Dysfunction | 1 | 2015 | 4 | 0.030 |
Why?
|
| Laxatives | 1 | 2015 | 5 | 0.030 |
Why?
|
| Flavoring Agents | 1 | 2015 | 15 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2016 | 170 | 0.030 |
Why?
|
| Automobile Driving | 1 | 1995 | 54 | 0.030 |
Why?
|
| Balloon Occlusion | 1 | 2014 | 9 | 0.030 |
Why?
|
| Sclerotherapy | 1 | 2014 | 10 | 0.030 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2014 | 7 | 0.030 |
Why?
|
| Ligation | 1 | 2014 | 35 | 0.030 |
Why?
|
| Hypertension, Portal | 1 | 2014 | 14 | 0.030 |
Why?
|
| Pregnancy Tests | 1 | 2014 | 3 | 0.030 |
Why?
|
| Blood Coagulation Tests | 1 | 2014 | 7 | 0.030 |
Why?
|
| Quality Control | 1 | 2014 | 70 | 0.030 |
Why?
|
| Hematocrit | 1 | 2014 | 33 | 0.030 |
Why?
|
| Urinalysis | 1 | 2014 | 33 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 279 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 1998 | 417 | 0.030 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 2013 | 4 | 0.030 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2013 | 6 | 0.030 |
Why?
|
| Factor VIII | 1 | 2013 | 31 | 0.030 |
Why?
|
| Laboratory Personnel | 1 | 2013 | 3 | 0.030 |
Why?
|
| Contraceptives, Oral | 1 | 2013 | 25 | 0.030 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2014 | 63 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 413 | 0.030 |
Why?
|
| Thrombophilia | 1 | 2013 | 15 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2014 | 149 | 0.030 |
Why?
|
| Thalidomide | 1 | 2013 | 33 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2013 | 36 | 0.030 |
Why?
|
| Proctoscopy | 1 | 2013 | 3 | 0.030 |
Why?
|
| Therapeutic Irrigation | 1 | 2013 | 13 | 0.030 |
Why?
|
| Universities | 1 | 2014 | 151 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 2014 | 79 | 0.030 |
Why?
|
| Transfusion Reaction | 1 | 2013 | 46 | 0.030 |
Why?
|
| Cost Savings | 1 | 2013 | 53 | 0.030 |
Why?
|
| Orthopedic Procedures | 1 | 2013 | 42 | 0.030 |
Why?
|
| Peritonitis | 1 | 2013 | 33 | 0.030 |
Why?
|
| Catheters, Indwelling | 1 | 2013 | 63 | 0.030 |
Why?
|
| Image-Guided Biopsy | 1 | 2013 | 35 | 0.030 |
Why?
|
| Catheterization | 1 | 2013 | 109 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 1995 | 294 | 0.030 |
Why?
|
| Burns, Chemical | 1 | 2012 | 2 | 0.030 |
Why?
|
| Total Quality Management | 1 | 2013 | 56 | 0.030 |
Why?
|
| Keratoderma, Palmoplantar, Diffuse | 1 | 2012 | 3 | 0.030 |
Why?
|
| Ethanol | 1 | 2016 | 304 | 0.030 |
Why?
|
| Fructose | 1 | 2013 | 40 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2018 | 487 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2014 | 156 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2013 | 92 | 0.030 |
Why?
|
| Weight Loss | 1 | 2015 | 259 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2013 | 146 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 240 | 0.030 |
Why?
|
| Esophagectomy | 1 | 2012 | 43 | 0.030 |
Why?
|
| Esophageal Achalasia | 1 | 2012 | 29 | 0.030 |
Why?
|
| Bacteremia | 1 | 2013 | 94 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2013 | 286 | 0.020 |
Why?
|
| Hospitals | 1 | 2015 | 373 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2013 | 307 | 0.020 |
Why?
|
| Airway Management | 1 | 2012 | 54 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 444 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2014 | 521 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 846 | 0.020 |
Why?
|
| Singapore | 1 | 2010 | 10 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 455 | 0.020 |
Why?
|
| Tachycardia | 1 | 2010 | 27 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 636 | 0.020 |
Why?
|
| Inflammation | 1 | 2017 | 1091 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 951 | 0.020 |
Why?
|
| Writing | 1 | 2010 | 43 | 0.020 |
Why?
|
| Quebec | 1 | 2010 | 12 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 539 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2010 | 147 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2012 | 259 | 0.020 |
Why?
|
| Reference Standards | 1 | 2010 | 61 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 669 | 0.020 |
Why?
|
| Competency-Based Education | 1 | 2010 | 26 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2013 | 243 | 0.020 |
Why?
|
| Heart Rate | 1 | 2010 | 302 | 0.020 |
Why?
|
| Safety Management | 1 | 2010 | 142 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2010 | 124 | 0.020 |
Why?
|
| Biomarkers | 1 | 2014 | 1199 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 1277 | 0.020 |
Why?
|
| Smoking | 1 | 2013 | 829 | 0.020 |
Why?
|
| Emotions | 1 | 2010 | 216 | 0.020 |
Why?
|
| Quality of Life | 1 | 2014 | 1102 | 0.020 |
Why?
|
| Anxiety | 1 | 2010 | 390 | 0.020 |
Why?
|
| Education, Medical, Graduate | 1 | 2010 | 298 | 0.020 |
Why?
|
| Narcotics | 1 | 2007 | 50 | 0.020 |
Why?
|
| Cognition | 1 | 2010 | 456 | 0.020 |
Why?
|
| Communication | 1 | 2010 | 531 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 5045 | 0.010 |
Why?
|
| Leukopenia | 1 | 1999 | 16 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1999 | 126 | 0.010 |
Why?
|
| Creatinine | 1 | 1999 | 121 | 0.010 |
Why?
|
| South Dakota | 1 | 1995 | 5 | 0.010 |
Why?
|
| Seat Belts | 1 | 1995 | 11 | 0.010 |
Why?
|
| Emulsions | 1 | 1999 | 447 | 0.010 |
Why?
|